Sagent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has fifty-two approved drugs.
Drugs and US Patents for Sagent Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 203609-002 | Feb 17, 2016 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Sagent Pharms Inc | DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 204751-001 | Aug 22, 2017 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Sagent Pharms Inc | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 203609-001 | Feb 17, 2016 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090581-001 | Oct 20, 2015 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Sagent Pharms Inc | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 204693-002 | Mar 7, 2018 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.